Company Filing History:
Years Active: 2015
Title: Kim-Hien Dao: Innovator in Cancer Stem Cell Research
Introduction
Kim-Hien Dao is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of cancer research, particularly in understanding cancer stem cells and their self-renewal potential. His innovative work has led to the development of a patent that addresses critical aspects of cancer treatment and diagnosis.
Latest Patents
Kim-Hien Dao holds a patent titled "Compositions and methods for determining cancer stem cell self-renewal potential." This invention provides compositions and methods for determining the self-renewal potential of cancer stem cells (CSCs) through the analysis of the cross-talk between cell self-renewal pathways. The patent also focuses on predicting the drugability of CSCs and the progression of cancer corresponding to these cells. The method involves detecting and quantifying various B-cell lymphoma-2 (Bcl-2) family protein isoforms or transcripts in CSCs. Additionally, it includes methods to measure levels of Wnt, glycogen synthase kinase-3 beta (GSK-3 beta), glycogen synthase kinase-3 alpha (GSK-3 alpha), and Sonic Hedgehog Homolog (SHH) family proteins for diagnostic and prognostic purposes. Kim-Hien Dao has 1 patent to his name.
Career Highlights
Kim-Hien Dao is affiliated with the University of California, where he continues to advance his research in cancer biology. His work is pivotal in the ongoing quest to improve cancer therapies and patient outcomes.
Collaborations
He has collaborated with esteemed colleagues such as Catriona Jamieson and Annelie Schairer, contributing to a rich environment of innovation and discovery in cancer research.
Conclusion
Kim-Hien Dao's contributions to cancer stem cell research exemplify the impact of innovative thinking in the medical field. His patent reflects a commitment to advancing our understanding of cancer and improving treatment strategies.